Los Angeles Capital Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $46.6M | Sell |
971,927
-257,109
| -21% | -$11.3M | 0.18% | 111 |
|
|
2025
Q4 | $45.4M | Buy |
1,229,036
+212,294
| +21% | +$8.1M | 0.15% | 105 |
|
|
2025
Q3 | $35.9M | Buy |
1,016,742
+699,991
| +221% | +$25.3M | 0.12% | 126 |
|
|
2025
Q2 | $11.4M | Sell |
316,751
-764,377
| -71% | -$25.3M | 0.04% | 230 |
|
|
2025
Q1 | $33.7M | Buy |
1,081,128
+1,040,234
| +2,544% | +$33M | 0.15% | 121 |
|
|
2024
Q4 | $1.04M | Sell |
40,894
-346,803
| -89% | -$9.2M | ﹤0.01% | 606 |
|
|
2024
Q3 | $11M | Sell |
387,697
-57,851
| -13% | -$1.6M | 0.04% | 241 |
|
|
2024
Q2 | $11.7M | Sell |
445,548
-258,371
| -37% | -$7.16M | 0.04% | 243 |
|
|
2024
Q1 | $21.4M | Buy |
703,919
+297,948
| +73% | +$8.78M | 0.07% | 206 |
|
|
2023
Q4 | $11.4M | Sell |
405,971
-25,575
| -6% | -$703K | 0.04% | 255 |
|
|
2023
Q3 | $11.7M | Buy |
431,546
+126,180
| +41% | +$3.75M | 0.05% | 229 |
|
|
2023
Q2 | $9.39M | Sell |
305,366
-241,368
| -44% | -$8.18M | 0.04% | 268 |
|
|
2023
Q1 | $19.7M | Buy |
546,734
+280,435
| +105% | +$10.4M | 0.09% | 196 |
|
|
2022
Q4 | $10.5M | Buy |
266,299
+98,126
| +58% | +$4.1M | 0.05% | 272 |
|
|
2022
Q3 | $6.76M | Sell |
168,173
-85,093
| -34% | -$3.63M | 0.04% | 317 |
|
|
2022
Q2 | $10.6M | Sell |
253,266
-41,133
| -14% | -$1.69M | 0.05% | 269 |
|
|
2022
Q1 | $11.5M | Buy |
294,399
+112,068
| +61% | +$4.4M | 0.05% | 262 |
|
|
2021
Q4 | $7.27M | Sell |
182,331
-158,648
| -47% | -$6.16M | 0.03% | 306 |
|
|
2021
Q3 | $12.3M | Sell |
340,979
-629,027
| -65% | -$24.4M | 0.06% | 246 |
|
|
2021
Q2 | $39.8M | Buy |
970,006
+80,255
| +9% | +$3.41M | 0.18% | 127 |
|
|
2021
Q1 | $38.8M | Buy |
889,751
+628,606
| +241% | +$29.8M | 0.18% | 131 |
|
|
2020
Q4 | $13.1M | Buy |
+261,145
| New | +$11.1M | 0.06% | 238 |
|
Other funds holding RPRX
